Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Nutex To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Nutex between August 8, 2024 and August 15, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK, Sept. 03, 2025 (GLOBE NEWSWIRE) -- Faruqi & Fa ...

Presentation Stephen BaxterSenior Equity Analyst Okay. Perfect. All right. So good morning, everyone. Thanks for joining us. I'm Steve Baxter, the Healthcare services analyst here at Wells Fargo. We're very pleased to have Tenet Healthcare with us this morning. As you likely know, Tenet operates a network of ASCs, acute care hospitals and a revenue cycle management business. From the company, we're happy to have CEO, Saum Sutaria; CFO, Sun Park, and Will McDowell from Investor Relations. Thanks again for ...

Financial Data and Key Metrics Changes - The company reiterated its earnings guidance for the year, including increases in EBITDA and free cash flow guidance following Q2 results [3] - The leverage ratio is reported to be just above three times EBITDA minus non-controlling interests, indicating a strong balance sheet [3] Business Line Data and Key Metrics Changes - The majority of the guidance increase was attributed to core operating performance, with strong volumes and acuity in the hospital space, alongside effective operating expense controls [7] - The company reported a strong performance in the USPI segment, with same-store revenue growth of over 7% in the first half of the year [40] Market Data and Key Metrics Changes - The company noted that the demand forecast for the second half of the year remains unchanged despite volume fluctuations in Q2, indicating confidence in operational performance [13] - The company is actively engaged in discussions regarding the extension of premium tax credits, which are seen as crucial for small businesses and the healthcare industry [17][20] Company Strategy and Development Direction - The company is focused on a high-acuity strategy, which has proven to be less elastic and more resilient to demand variations, allowing for consistent earnings generation [10] - There is an emphasis on capital investment in clinical technologies and growth strategies, with plans to pull forward capital expenditures to drive market share [35][36] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the operational excellence demonstrated in Q2, despite industry-wide volume weaknesses [9] - The company is preparing for potential policy changes and is focused on maintaining operational resilience and growth opportunities [36] Other Important Information - The company has seen stable operating conditions regarding labor and supply costs, with professional fees growing at a manageable rate [39] - Conifer Health Solutions is expanding its services and has maintained strong margins despite challenges in the market [52][54] Q&A Session All Questions and Answers Question: How would you characterize the core performance excluding Medicaid figures? - The majority of the guidance increase was based on organic performance, with strong volumes and operating expense controls contributing significantly [7] Question: What are the expectations for the second half of the year regarding demand? - The company has not changed its demand forecast and remains focused on operational improvements to drive earnings [13] Question: What is the company's stance on the potential extension of premium tax credits? - There is increasing political recognition of the importance of extending premium tax credits, which could benefit small businesses and the healthcare sector [17][20] Question: How does the company view its capital investment strategy moving forward? - The company is confident in its ability to invest in growth opportunities while also returning capital to shareholders, maintaining a balanced approach [47]

New York City Health + Hospitals has been working with Oracle Fusion Applications since November 2024. To learn more about Oracle Fusion Applications, please visit: oracle.com/applications About Oracle Largest municipal health care system in the U.S. consolidates finance, supply chain, and HR processes with Oracle Fusion Cloud Applications to integrate systems, standardize operations, and enhance the employee and patient experience System-wide consolidation will increase IT security and reduce reliance on o ...

Core Viewpoint - A class action lawsuit has been filed against Nutex Health Inc. for failing to disclose fraudulent activities by its third-party arbitration vendor, HaloMD, which has raised concerns about the legitimacy of the company's reported revenues and financial health [2][3]. Group 1: Allegations and Concerns - Nutex Health Inc. allegedly engaged in a scheme with HaloMD that defrauded insurance companies, leading to unsustainable revenue figures [2]. - The company is accused of overstating its ability to remediate internal control weaknesses, affecting its financial reporting and stock-based compensation calculations [2]. - A short report by Blue Orca Capital highlighted that Nutex's recent 20-fold share price surge was artificially inflated due to HaloMD's practices, raising doubts about the company's financial performance [3]. Group 2: Financial Impact - Following the announcement of a delay in filing quarterly financial statements due to incomplete accounting adjustments, Nutex's stock price dropped over 16% [4]. - The potential cessation of revenue benefits from HaloMD's billing practices could lead to a significant decline in Nutex's financial performance, possibly reverting its stock to penny-stock levels [3]. Group 3: Legal Proceedings - Shareholders are encouraged to participate in the class action lawsuit against Nutex Health Inc., with options to serve as lead plaintiff or remain an absent class member [5]. - Robbins LLP, the law firm handling the case, operates on a contingency fee basis, meaning shareholders incur no fees or expenses unless a recovery is achieved [6].

Here are three stocks with buy rank and strong value characteristics for investors to consider today, September 2nd:  Jackson Financial (JXN) : This company which is a U.S. retirement services provider, supported by its diverse portfolio of differentiated products, carries a Zacks Rank #1 (Strong Buy), and has witnessed the Zacks Consensus Estimate for its current year earnings increasing 5.9% over the last 60 days.Jackson Financial has a price-to-earnings ratio (P/E) of 4.83 compared with 10.60 for the ind ...

HealthEquity, Inc. HQY will release earnings results for the second quarter after the closing bell on Tuesday, Sept. 2.Analysts expect the Draper, Utah-based company to report quarterly earnings at 92 cents per share, up from 86 cents per share in the year-ago period. HealthEquity projects to report quarterly revenue of $320.69 million, compared to $299.93 million a year earlier, according to data from Benzinga Pro.On June 3, HealthEquity reported first-quarter earnings of 97 cents per share, which beat the ...

Group 1: Asset Purchase Agreement - Aja Health and Wellness Inc. has signed an Asset Purchase Agreement to acquire assets from Canadian Travel and Doctors Clinics Inc. for a purchase price of CAD 150,000 [2] Group 2: Share Subscription Agreement - Aja has entered into a Share Subscription Agreement with GEM Global Yield LLC SCS, agreeing to subscribe for up to CAD 25 million of securities over three years [3] - The Subscription Agreement allows Aja to issue Draw Down Notices to request capital from GEM, subject to certain conditions [4] Group 3: Financial Obligations and Fees - Aja has agreed to pay a fee of CAD 500,000 to GEM Yield Bahamas Limited, which can be paid in various forms including cash or Common Shares [6] Group 4: Financial Reporting and Compliance - Aja is working to file its annual audited financial statements for the year ending December 31, 2024, and interim financial statements for the three months ended March 31, 2025, by September 15, 2025 [7][9] - The delay in filing is due to the need for a valuation related to a previous reverse takeover transaction [8]

LOS ANGELES, Aug. 29, 2025 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP reminds investors of the upcoming October 21, 2025 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Nutex Health Inc. (“Nutex” or the “Company”) (NASDAQ: NUTX) securities between August 8, 2024 and August 14, 2025, inclusive (the “Class Period”). IF YOU SUFFERED A LOSS ON YOUR NUTEX INVESTMENTS, CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING CLAIMS TO RECO ...

Recognizing Healthcare's Data-Driven Innovators at the 2025 Health Catalyst Analytics Summit SALT LAKE CITY, Aug. 29, 2025 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst,"Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced the winners of the 2025 Catalyst Awards, an annual program recognizing healthcare organizations at the forefront of data-driven transformation. The Catalyst Awards were presented at the Health Catalyst Analy ...